Prospecto:Information for the Patient
Vaxar Plus 15mg/10mg Tablets
Vaxar Plus 30mg/10mg Tablets
Vaxar Plus 40mg/10mg Tablets
rosuvastatina and ezetimiba
Read this prospectus carefully before starting to take this medication,because it contains important information for you.
-This medication has been prescribedonlyto you, and you should not give it to other people even iftheyhave the same symptomsas you,as it may harm them.
1.What is Vaxar Plus and what is it used for
2.What you need to knowbeforestarting totake Vaxar Plus
3.How to take Vaxar Plus
4.Possible adverse effects
5Storage of Vaxar Plus
6.Contents of the package and additional information
Rosuvastatina/ezetimiba contains two different active principles in one tablet. One of the active principles is rosuvastatina, which belongs to the group of medications called statins, the other active principle is ezetimiba.
Vaxar Plus tablets are a medication used to reduce total cholesterol levels, "bad" cholesterol (LDL cholesterol) and certain fatty substances called triglycerides that circulate in the blood. Additionally, it increases the concentrations of "good" cholesterol (HDL cholesterol). This medication acts by reducing cholesterol in two ways: reducing the cholesterol absorbed in the digestive tract, as well as the cholesterol produced by the body itself.
For most people, high cholesterol levels do not affect how they feel since they do not produce any symptoms. However, if left untreated, fatty deposits can accumulate in the walls of blood vessels and narrow them.
At times, these narrowed blood vessels can become blocked, cutting off blood supply to the heart or brain, which would cause a heart attack or stroke. By reducing cholesterol levels, the risk of having a heart attack, stroke, or other related health problems can be reduced.
Rosuvastatina/ezetimiba is used in patients who cannot control their cholesterol levels solely with diet. While taking this medication, a cholesterol-reducing diet should be followed.
Your doctor may prescribe Vaxar Plus if you are already taking rosuvastatina and ezetimiba at the same dosage level.
Rosuvastatina/ezetimiba is used if you have:
This medication does not help with weight loss.
Do not take Vaxar Plus if:
If you find yourself in any of the above situations (or are unsure), please consult your doctor.
Additionally, do not take Vaxar Plus 40 mg/10 mg (the highest dose) if:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Vaxar Plus if:
If you find yourself in any of these situations mentioned above (or are unsure): do not take Vaxar Plus 40 mg/10 mg (the highest dose) and consult your doctor or pharmacist before starting to take any dose of Vaxar Plus tablets.
In a reduced number of people, statins can affect the liver. This is detected by a simple test that detects increased levels of liver enzymes in the blood. For this reason, your doctor will usually perform blood tests (liver function test) during treatment with Vaxar Plus. It is essential that you go to the doctor for the tests.
While taking this medication, your doctor will closely monitor you if you have diabetes or are at risk of developing diabetes. You may be at risk of developing diabetes if you have high sugar and fat levels in your blood, are overweight, and have high blood pressure.
Severe skin reactions, including Stevens-Johnson syndrome and drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported associated with rosuvastatin treatment. Stop using Vaxar Plus and seek medical attention immediately if you notice any of the symptoms described in section 4.
Children and adolescents
Vaxar Plus is not recommended for use in children and adolescents under 18 years of age.
Other medications and Vaxar Plus tablets
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Inform your doctor if you are taking any of the following medications:
If you go to a hospital or receive treatment for another disease, inform the medical staff that you are taking Vaxar Plus tablets.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, consult your doctor or pharmacist before using this medication.
Pregnancy
Do not take Vaxar Plus tabletsif you are pregnant, think you might be pregnant, or intend to become pregnant. If you become pregnant while taking Vaxar Plus tablets,stop taking it immediatelyand inform your doctor. Women should use contraceptive methods during treatment with Vaxar Plus.
Breastfeeding
Do not take Vaxar Plus tablets,if you are breastfeeding, as it is unknown whether the medication passes into breast milk.
Driving and operating machinery
Vaxar Plus tablets are not expected to interfere with your ability to drive or operate machinery. However, some people may feel dizzy after taking Vaxar Plus tablets. If you feel dizzy, consult your doctor before attempting to drive or operate machinery.
Vaxar Plus tablets contain lactose monohydrate
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Vaxar Plus tablets contain sodium
This medication contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially “sodium-free”.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
You should continue to maintain a low-cholesterol diet and exercise while taking Vaxar Plus tablets.
The recommended daily dose for adults is one tablet of the indicated dose.
Take Vaxar Plus tablets once a day.
You can take it at any time of the day, with or without food. Swallow each tablet whole with water.
Take your medication at the same time every day.
Vaxar Plus tabletsare not suitable for starting treatment. The start of treatment or dose adjustments, if necessary, should only be made by taking the active ingredients separately, and once the appropriate doses have been adjusted, it is possible to switch to the appropriate dose ofVaxar Plus tablets.
The maximum daily dose of rosuvastatin is 40 mg. This dose is only for patients with high cholesterol levels and a high risk of suffering a heart attack or stroke, whose cholesterol levels do not decrease enough with 30 mg.
Regular cholesterol level checks
It is essential that you attend your doctor regularly for cholesterol checks, in order to verify that your cholesterol levels have normalized and are maintained at appropriate levels.
If you take more Vaxar Plus tablets than you should
Contact your doctor or the nearest hospital's emergency service as you may need medical assistance.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Vaxar Plus tablets
Do not worry, omit the missed dose and take the next scheduled dose at the scheduled time. Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Vaxar Plus tablets
Consult your doctor if you want to discontinue treatment withVaxar Plus tablets. Your cholesterol levels may increase again if you stop takingVaxar Plus tablets.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
It is important that you know which side effects may occur.
Stop taking Vaxar Plus tablets and seek medical assistance immediatelyif you experience any of the following allergic reactions:
Also, stop taking Vaxar plus and consult your doctor immediately if you experience unusual muscle pain that lasts longer than expected. In rare cases, this may develop into a potentially fatal muscle injury known as rhabdomyolysis, which causes general discomfort, fever, and kidney damage.
The following terms are used to describe how often side effects have been reported:
Very common side effects (may affect more than 1 in 10 people)
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Very rare side effects (may affect up to 1 in 10,000 people, including isolated cases)
Common side effects
Uncommon side effects
Rare side effects
Very rare side effects
Jaundice (yellowing of the skin and eyes); liver inflammation (hepatitis); blood in the urine; nerve damage in the legs and arms (numbness); memory loss; breast enlargement in men (gynecomastia).
Unknown frequency
Difficulty breathing; edema (swelling); sleep disturbances, including insomnia and nightmares; sexual dysfunction; depression; respiratory problems, including persistent cough and/or difficulty breathing or fever; tendon injuries; persistent muscle weakness; red, raised rash, sometimes with target-shaped lesions (erythema multiforme); muscle sensitivity; gallstones or inflammation of the gallbladder (which may cause stomach pain, nausea, vomiting);
Miyasthenia gravis (a disease that causes generalized muscle weakness, which in some cases affects the muscles used for breathing); myasthenia ocular (a disease that causes weakness of the eye muscles).
Consult your doctor if you experience weakness in the arms or legs that worsens after
periods of activity, double vision, eyelid drooping, difficulty swallowing, or difficulty breathing.
Reporting side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Store in the original packaging to protect it from light. This medication does not require special storage conditions.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after “CAD”. The expiration date is the last day of the month indicated.
Do not dispose of medications through drains or trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition ofVaxar Plus
The active principles are rosuvastatina (as rosuvastatina calcium) and ezetimiba. The tablets contain rosuvastatina calcium equivalent to 15 mg, 30 mg or 40 mg of rosuvastatina. Each tablet contains 10 mg of ezetimiba.
The other components are: lactose monohydrate, microcrystalline cellulose, sodium croscarmellose, crospovidone type A, povidone K-30, sodium laurilsulfate and magnesium stearate.
Appearance of the product and contents of the packaging
Vaxar Plus 15 mg/10 mg: Uncoated hexagonal biconvex tablet of white to off-white color, with approximate dimensions of 9 x 8 mm and with "E3" engraved on both faces.
Vaxar Plus 30 mg/10 mg: Uncoated biconvex tablet of white to off-white color, rectangular shape, with dimensions of 12 x 6 mm and with an "X" engraved on both faces.
Vaxar Plus 40 mg/10 mg: Uncoated biconvex elliptical tablet of white to off-white color, with approximate dimensions of 13 x 6 mm and with "E6" engraved on both faces.
This medication is available in packaging of 28, 30, 56, 60 and 90 tablets
Only some sizes of packaging may be commercially marketed.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
Adamed Laboratorios, S.L.U.
c/ de las Rosas de Aravaca, 31 - 2nd floor
28023 Madrid
Spain
Responsible for manufacturing
Adamed Pharma S.A.
Ul. Marszalka Jósefa Pilsudskiego 5
95-200 Pabianice, Lodzkie
Poland
This medication is authorized in the member states of the European Economic Areawiththe following names:
Poland:Vaxar Plus
Spain:Vaxar Plus 15mg/10mg tablets
Vaxar Plus 30mg/10mg tablets
Vaxar Plus 40mg/10mg tablets
Last review date of this prospectus: March 2024
Detailed information about this medication is available on the website of the {Spanish Agency of Medicines and Medical Devices (AEMPS)} (http://www.aemps.gob.es/)
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.